Open access · CC-BY
via OpenAlex
DNA methylation-based clocks, tobacco smoking, and lung cancer risk
Ricardo Cortez Cardoso Penha, Justina Ucheojor Onwuka, Ryan Langdon, Torkjel Manning Sandanger, Therese Haugdahl Nøst, Paolo Vineis, Mikael Johansson, Roger Laughlin Milne, Pierre‐Antoine Dugué, Caroline L. Relton, Matthew J Suderman, James McKay, Mattias Johansson
BMC Medicine · 2025 · ▲ 2 citations
Abstract
Biological age, estimated by DNA methylation-based (DNAm) clocks, has been reported to be associated with lung cancer risk. However, the extent to which tobacco smoking behaviours can explain this association and the extent to which DNAm clocks and their components can inform risk assessment for lung cancer remains to be elucidated. This study aimed to evaluate the relationship between DNAm clocks, smoking, and lung cancer risk. We analyzed four prospective cohorts (MCCS, Australia, 324 cases/324 controls; NSHDS, Sweden, 190 cases/190 controls; EPIC, Italy, 160 cases/107 controls; and NOWAC, Norway, 115 case/70 controls) with blood samples collected before lung cancer diagnosis. Study participants were restricted to those with a history of smoking. Incidence sampling was used to match one control to each of the lung cancer cases by cohort, sex, date of blood collection, age, and smoking status in MCCS and NSHDS. The risk discriminative performance of age-adjusted DNAm clocks and their components was compared with that of the Prostate, Lung, Colorectal, and Ovarian model 2012 (PLCO m2012 ) lung cancer risk model. We found several DNAm clocks positively associated with lung cancer risk (Hannum: OR = 1.13, 95% CI = 1.02–1.26; PhenoAge: OR = 1.25, 95% CI = 1.12–1.40; DunedinPACE: OR = 1.44, 95% CI = 1.29–1.62; PCGrimAge (a principal component-denoised GrimAge): OR = 1.79, 95% CI = 1.56–2.06), after adjustment for age and tobacco smoking. Tobacco smoking explained a modest proportion of variance in most age-adjusted DNAm clocks ( R 2 < 11%), except for PCGrimAge, where it accounted for ~ 30% of variance in both lung cancer cases and controls. Detailed smoking adjustments attenuated the PCGrimAge association with lung cancer risk by 13%. In a secondary analysis adjusting for PCGrimAge components and the PLCO m2012 score, DNA methylation-predicted packyears emerged as an independent predictor of lung cancer risk (OR = 2.23, 95% CI = 1.58–3.14). The area under the receiver operating characteristic curve (AUC) for the PLCO m2012 model was 0.66 (95% CI = 0.61–0.71) compared with 0.72 (95% CI = 0.67–0.77) for the PCGrimAge model ( P difference = 0.03). Combining PCGrimAge with PLCO m2012 provided similar risk discrimination as PCGrimAge alone (AUC = 0.72, 95% CI = 0.67–0.77). Methylation-based biological clocks capture epigenetic marks left by exposure to tobacco smoke, and some clocks may inform lung cancer risk assessment by complementing or replacing traditional prediction models.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12916-025-04542-9
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Penha, R.C.C., Onwuka, J.U., Langdon, R., Sandanger, T.M., Nøst, T.H., Vineis, P., Johansson, M., Milne, R.L., Dugué, P., Relton, C.L., Suderman, M.J., McKay, J., & Johansson, M. (2025). DNA methylation-based clocks, tobacco smoking, and lung cancer risk. <em>BMC Medicine</em>. https://doi.org/10.1186/s12916-025-04542-9
Vancouver
Penha RCC, Onwuka JU, Langdon R, Sandanger TM, Nøst TH, Vineis P, et al. DNA methylation-based clocks, tobacco smoking, and lung cancer risk. BMC Medicine. 2025. doi:10.1186/s12916-025-04542-9.
BibTeX
@article{ricardo2025DNAmet,
title = {DNA methylation-based clocks, tobacco smoking, and lung cancer risk},
author = {Ricardo Cortez Cardoso Penha and Justina Ucheojor Onwuka and Ryan Langdon and Torkjel Manning Sandanger and Therese Haugdahl Nøst and Paolo Vineis and Mikael Johansson and Roger Laughlin Milne and Pierre‐Antoine Dugué and Caroline L. Relton and Matthew J Suderman and James McKay and Mattias Johansson},
journal = {BMC Medicine},
year = {2025},
doi = {10.1186/s12916-025-04542-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC medicine 2025
Open access · OA
DNA methylation-based clocks, tobacco smoking, and lung cancer risk.
African Health Sciences 2019
Open access · CC-BY
Association of inflammatory biomarkers with lung cancer in North Indian population
Scientific Reports 2019
Open access · CC-BY
DNA methylation-based biological age, genome-wide average DNA methylation, and conventional breast cancer risk factors
Breast Cancer Research 2022
Open access · CC-BY
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies
Research Square 2022
Preprint · CC-BY
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies
International Journal of Environmental Research and Public Health 2019
Open access · CC-BY